Skip to content
Governance Register

← US public companies

Baker Brothers Life Sciences Capital (GP), LLC

SEC-identified person · CIK 1307729 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Tranzyme INC TZYM Officer filed 2012 - 2012
Genomic Health INC GHDX Director filed 2006 - 2012
Xoma Royalty Corp XOMAD Officer filed 2012 - 2012
Intrabiotics Pharmaceuticals INC /DE RDEA Director filed 2006 - 2012
Pharmacyclics INC pcyc Officer filed 2011 - 2012
Incyte Corp INCY Director filed 2007 - 2012
Trimeris INC TRMS Director filed 2006 - 2012
Seagen Inc. SGEN Director filed 2006 - 2012
Adolor Corp adlr Officer filed 2010 - 2012
Viropharma INC VPHM Officer filed 2006 - 2011
Auxilium Pharmaceuticals INC AUXL Officer filed 2010 - 2011
Heron Therapeutics, INC. /DE/ appa Officer filed 2009 - 2011
Biocryst Pharmaceuticals INC BCRX Officer filed 2007 - 2011
Diadexus, Inc. vxgn Officer filed 2010 - 2010
Allos Therapeutics INC ALTH Officer filed 2006 - 2009
Neurogen Corp NRGN Director filed 2006 - 2008
Tapestry Pharmaceuticals, INC TPPH Officer filed 2006 - 2008
Idera Pharmaceuticals, INC. IDRA Officer filed 2006 - 2008
Synvista Therapeutics, Inc. SYI Officer filed 2007 - 2007

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.